Skip to search formSkip to main contentSkip to account menu

aclidinium

Known as: (3-Carbamoyl-3,3-diphenylpropyl)ethyldimethylammonium 
National Institutes of Health

Related topics

Related topics

3 relations
30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza]aclidinium bromide

Narrower (1)

Tudorza

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Эпоха двойной бронходилатации: первые прямые сравнения и метаанализы
The aim of this review was to summarize recently published data on dual bronchodilation in patients with chronic obstructive… 
2016
2016
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity
2014
2014
Cost-Effectiveness of Aclidinium Bromide Compared with Tiotropium Bromide from the Perspective of Copd Patient Populations
Objective: To assess the cost­effectiveness of aclidinium vs. tiotropium in GOLD II, III, & IV COPD patients from the perspective… 
2014
2014
Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed Dose Combination via Pressair/Genuair vs Formoterol via Foradil Aerolizer in Patients With Moderate to Severe COPD
2013
2013
New use of aclidinium
The present invention provides aclidinium or any of its steroisomers or mixture of stereoisomers, or a pharmaceutically… 
2012
2012
Aclidinium bromide oral inhalation powder approved for COPD.
FDA on July 23 approved aclidinium bromide oral inhalation powder for long-term maintenance therapy in patients with chronic… 
2011
2011
Translational models of disease P 840 Transient receptor potential ankyrin 1 ( TRPA 1 )-mediated cough
printing supported by . Visit Chiesi at Stand D.30 SUNDAY, SEPTEMBER 25TH 2011 P844 Fluticasone furoate, a novel corticosteroid… 
2009
2009
Inhalation composition containing aclidinium treatment chronic obstructive pulmonary disease
A pharmaceutical composition comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture… 
1997
1997
Manufacturing method of acridone derivatives and 8-hydroxy-imidazo aclidinium Non derivative
(57) [summary] the general formula (I) (Wherein, R (Here, A is a hydroxy protecting group which can be removed by reduction) of 1… 
1984
1984
“FDA-approved” indications